Sangamo Therapeutics Inc.
Analyst Coverage - Sangamo Therapeutics, Inc.
Investors & Media ... Gena Wang, Ph.D. ... Debjit Chattopadhyay, Ph.D. ... Maury Raycroft, Ph.D. Jefferies. Luca Issi, Ph.D. ... Sangamo Therapeutics, Inc. is followed ...
Sangamo Therapeutics Inc. (SGMO) - Stock Price, Quote, News ...
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' ...
SGMO - Sangamo Therapeutics, Inc. (NasdaqCM) - Share Price and ...
Sangamo Therapeutics, Inc., based in the United States, operates within the biotechnology industry, specializing in genomic medicine.
Sangamo Therapeutics, Inc. Stock (SGMO) - Quote Nasdaq
Sangamo Therapeutics, Inc. (SGMO.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Sangamo Therapeutics, ...
SGMO Sangamo Therapeutics Inc - Stocktwits
Track Sangamo Therapeutics Inc (SGMO) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Sangamo Therapeutics Inc. Profile - SGMO - MarketWatch
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins.
Genentech and Sangamo to develop new therapies
Genentech and Sangamo to develop neurodegenerative disease therapies ... Sangamo could receive $1.9bn in development and commercial milestones ...
Sales Intelligence Solution. Understand how Sangamo Therapeutics Inc fits into your total addressable market and Ideal Customer Profile. Gain competitive edge ...
SANGAMO THERAPEUTICS, INC. (SGMO) Stock, Price ... - MSN
Track SANGAMO THERAPEUTICS, INC. (SGMO) price, historical values, financial information, price forecast, and insights to empower your investing journey ...
Sangamo Therapeutics Inc. (SGMO) Stock Price Today - WSJ
PRE MARKET Vol 5,969 · Volume9,919,278 · 65 Day Avg Vol7,203,825 · 1 Day Range2.25 - 2.82 · 52 Week Range0.304 - 3.179(07/05/24 - 11/08/24).
Sangamo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore Sangamo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 35 clinical trials, 220 news, and 268 literature, ...
Sangamo Therapeutics Inc. Company & People | SGMO - Barron's
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins.
Roche inks US$2bn biobucks deal with Sangamo
After Sangamo Therapeutics Inc. presented an epigenetic ZFN-based repressor at ASGCT 2024 that reduces the expression of the tau protein in ...
SANGAMO THERAPEUTICS, INC SEC 10-Q Report - TradingView
Sangamo Therapeutics, Inc., a biotechnology company focused on developing genomic medicines for serious diseases, has released its Form 10-Q ...
Case Western Reserve and Sangamo Therapeutics Announce $11 ...
Case Western Reserve University and Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the award of an $11 million grant from the ...
SGMO - Sangamo Therapeutics, Inc. Latest Stock News & Market ...
Sangamo Therapeutics, Inc. (SGMO) is a pioneering genomic medicine company dedicated to the development of transformative therapies for patients suffering from ...
Sangamo Therapeutics Presents Initial Safety Data from ...
PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the presentation of initial safety data from the CHAMPIONS Study, the Phase 1/2...
Biogen and Sangamo Announce Global Collaboration to Develop ...
27, 2020 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today ...
Sangamo Therapeutics, Inc. (SGMO) Q1 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ETCompany ParticipantsLouise Wilkie - Vice ...
Sangamo Therapeutics Announces Q2 2024 Results and Business ...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, has announced key business highlights and financial results for the ...
Sangamo Therapeutics
Biotechnology companySangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.